10 Pancreatic Cancer Clinical Trials in Scottsdale, AZ (2026)

Q: How do I join a clinical trial in Scottsdale?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Scottsdale research site will contact you.

Recruiting Pancreatic Cancer Studies in Scottsdale

NCT06271291Recruiting

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

This study evaluates individuals without pancreatic cancer, but who have been determined to be at higher-than-average lifetime risk of developing pancreatic cancer to help detect pancreatic cancer or ...

Scottsdale, AZ30,000 participantsMayo Clinic

View Study Details

NCT06388967Recruiting

Pancreatic Cancer Detection Consortium

This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma....

Scottsdale, AZ2,000 participantsCity of Hope Medical Center

View Study Details

NCT07491445Recruiting

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

The purpose of this study is to evaluate the safety and efficacy of an investigational RAS(ON) inhibitor administered as monotherapy or in combination with chemotherapy, compared with standard of care...

Scottsdale, AZPHASE3900 participantsRevolution Medicines, Inc.

View Study Details

NCT07252232Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard of care (SOC) observation only....

Scottsdale, AZPHASE3500 participantsRevolution Medicines, Inc.

View Study Details

NCT06958328Recruiting

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

This phase III trial compares the effect of dose-escalated radiation therapy to usual care in patients with locally advanced unresectable pancreatic ductal adenocarcinoma who have received an initial ...

Scottsdale, AZPHASE3356 participantsNRG Oncology

View Study Details

NCT06922591Recruiting

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

TNG462-C102 is a Phase 1/2, open-label, multicenter study designed to determine the safety, tolerability, PK, PD, and preliminary antineoplastic activity of oral TNG462 in combination with RMC-6236 or...

Scottsdale, AZPHASE1183 participantsTango Therapeutics, Inc.

View Study Details

NCT04683315Recruiting

PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples

This is an open-label, phase II study in patients with resectable and borderline resectable pancreatic cancer....

Scottsdale, AZPHASE284 participantsMedical College of Wisconsin

View Study Details

NCT06698458Recruiting

Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

This is a multi-center clinical study enrolling up to 30 participants (15 patients in each cohort). The primary objective of the study is to evaluate the safety of Alpha DaRT in combination with chemo...

Scottsdale, AZNA50 participantsAlpha Tau Medical LTD.

View Study Details

NCT07226856Recruiting

BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

This phase II trial tests the safety, side effects and best dose of BMS-986340 in combination with nivolumab, gemcitabine, and nab-paclitaxel and how well it works in treating patients with pancreatic...

Scottsdale, AZPHASE243 participantsMayo Clinic

View Study Details

NCT06850623Recruiting

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

The purpose of the study is to assess the efficacy and safety of Acoustic Cluster Therapy (ACT) when given in addition to chemotherapy for treatment of Locally Advanced Pancreatic Cancer....

Scottsdale, AZPHASE225 participantsEXACT Therapeutics AS

View Study Details

About Pancreatic Cancer Clinical Trials in Scottsdale

Pancreatic cancer begins in the tissues of the pancreas and is often diagnosed at an advanced stage. It is one of the most challenging cancers to treat. Clinical trials are actively investigating new approaches including immunotherapy and combination regimens.

There are currently 10 pancreatic cancer clinical trials recruiting participants in Scottsdale, AZ. These studies are seeking a combined 34,141 participants. Research is being sponsored by Mayo Clinic, City of Hope Medical Center, Revolution Medicines, Inc. and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pancreatic Cancer Clinical Trials in Scottsdale — FAQ

Are there pancreatic cancer clinical trials in Scottsdale?

Yes, there are 10 pancreatic cancer clinical trials currently recruiting in Scottsdale, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Scottsdale?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Scottsdale research site will contact you about next steps.

Are clinical trials in Scottsdale free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Scottsdale studies also compensate for your time and travel.

What pancreatic cancer treatments are being tested?

The 10 active trials in Scottsdale are testing new therapies including novel drugs, biologics, and treatment approaches for pancreatic cancer.

Data updated October 2, 2026 from ClinicalTrials.gov